by | Oct 21, 2025 | Lupus Foundation of America
The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research at the American College of Rheumatology (ACR) Convergence 2025 meeting in Chicago, IL, taking place October 24-29. The presented research will...
by | Oct 20, 2025 | Lupus Foundation of America
FDA approval of Gazyva expands therapeutic options for lupus careThe U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease....
by | Oct 15, 2025 | Lupus Foundation of America
In the U.S., flu and COVID season runs from October through March and sometimes a bit longer. Although you can catch the flu or COVID anytime of the year, you are more likely to get sick during the fall and winter months. More people meet indoors, school is back in...
by | Oct 9, 2025 | Lupus Foundation of America, News & Events
A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes, which may serve as potential biomarkers for early detection and monitoring. SLE...
by | Oct 2, 2025 | Lupus Foundation of America, News & Events
In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the Definition of Remission in SLE (DORIS remission). Many people did not reach...
by | Sep 26, 2025 | Lupus Foundation of America
In the Jewish tradition, Yom Kippur—the holiest day of the year—is a 25-hour Day of Atonement devoted to self-reflection, repentance (teshuvah), and prayer. Fasting during this time is intended to shift focus from physical needs to spiritual renewal and a deeper sense...
